Skip to main content
NCBI home page
Frontiers in Microbiology logoLink to Frontiers in Microbiology
. 2017 May 17;8:894. doi: 10.3389/fmicb.2017.00894

Transcriptional Responses of Candida albicans to Antimicrobial Peptide MAF-1A

Tao Wang 1, Jiangfan Xiu 1, Yingchun Zhang 1, Jianwei Wu 1,*, Xiaolin Ma 1, Yu Wang 2, Guo Guo 1, Xiaoli Shang 3
PMCID: PMC5434131  PMID: 28567034

Abstract

Candida albicans is a major fungal pathogen in humans. Novel antifungal agents are urgent demanded due to the challenges of the resistance. Antimicrobial peptides (AMPs) are critical components of the innate immune system against pathogenic microorganism infection. MAF-1A is a novel cationic AMP that comes from Musca domestica and is effective against C. albicans, but the antifungal mechanism remains unclear. In this study, we performed a transcriptomics analysis in C. albicans using RNA-seq technique under the treatment of MAF-1A. A total of 5654 genes were identified. Among these, 1032 were differentially expressed genes (DEGs), including 575 up-regulated genes and 457 down-regulated genes. In these DEGs, genes encoding ergosterol metabolism and fatty acid biosynthesis were identified to be significantly down-regulated, while genes associated with oxidative stress response and cell wall were identified to be significantly up-regulated. Using pathway enrichment analysis, 12 significant metabolic pathways were identified, and ribosome, oxidative phosphorylation, citrate cycle were mainly involved. The results revealed that MAF-1A induces complex responses in C. albicans. This study provides evidence that MAF-1A may inhibit the growth through affect multi-targets in C. albicans cells.

Keywords: Candida albicans, transcriptional responses, antimicrobial peptides, MAF-1A, RNA-Seq

Introduction

Candida albicans is an opportunistic fungal pathogen of humans that can cause human mycoses, ranging from superficial mucosal and skin to invasive candidiasis, especially in immunocompromised patients (Eggimann et al., 2003; Linares et al., 2013; Guilhelmelli et al., 2016). In the past two decades, infections caused by C. albicans have increased significantly (Lo et al., 2015). Invasive candidiasis has an estimated mortality about 40%, even with the use of antifungal drugs (Horn et al., 2009; Lu et al., 2014). Currently, only a limited number of antifungal agents are being used to treat these infections, including azoles, polyene, and echinocandins drugs. The persistent use of these drugs have caused the emergence of drug-resistant strains. The resistance and shortage of antifungal agents have potentially limited the management of infections. Besides being pathogenic, C. albicans also provides an excellent eukaryotic model system to explore the antifungal mechanisms of potent drugs (Khan et al., 2015).

Recently, the therapeutic application of antimicrobial peptides (AMPs) or their analogs have received a great deal of attention (Cruz et al., 2014; Lakshmaiah Narayana and Chen, 2015; Mahlapuu et al., 2016). AMPs are relatively small (less than 100 amino acid residues), cationic, amphipathic, variable in length, sequence or structure peptides which have been isolated from animals, plants, bacteria, or fungi (Pushpanathan et al., 2013; Malmsten, 2014; Silva et al., 2014). AMPs are important components of the innate immunity system against invading pathogens. Many AMPs are effective against multi-drug resistant (MDR) microorganism and less developing resistance due to their distinguished mode of action (Seo et al., 2012). Thus, AMPs could be promising candidates for developing novel therapeutic agents against fungi.

Musca domestica antifungal peptide-1 (MAF-1), isolated from the instar larvae of housefly, is a kind of a novel cationic AMP with excellent antimicrobial effect (Fu et al., 2009). In previous study, full-length of MAF-1 gene was cloned, and bioinformatics analysis was used to explore structure domain and its potential physiological function (Luo et al., 2013). MAF-1A peptide was derived from the structure domain of MAF-1 and contained 26 amino acid residues (KKFKETADKLIESAKQQLESLAKEMK). MAF-1A showed its remarkable antifungal effect (Luo et al., 2013; Zhou et al., 2016), but the detailed antifungal actions of MAF-1A remain unclear.

The classic action mechanism of AMPs is cause microbial cell membrane damage. So far, most research has been focused on the use of model membrane systems such as lipid vesicles, to determine the mode of action of AMPs. Even though this knowledge is essential in our understanding of the mode of action of AMPs, it does not fully explain their interaction with microbial cell membrane or the response of microbes to the AMPs (Omardien et al., 2016). In addition, it has been proposed that some AMPs can interact with intracellular specific targets inducing cell damages, such as the inhibition of DNA, RNA, protein and cell wall synthesis (Guilhelmelli et al., 2013; van der Weerden et al., 2013; Scocchi et al., 2016; Shah et al., 2016). The analysis of microbial transcriptome may contribute to the understanding of their interaction with novel AMPs (Tavares et al., 2013). The next generation sequencing technologies for transcriptome analysis have opened the opportunity to understand a wide variety of physiological response of microorganism affected by drugs or environmental conditions treatment. RNA-Seq (deep-sequencing of cDNA) has been used successfully to identify and quantify gene expression at a genome scale level. RNA-Seq shows significant advantages such as sensitive, resolution and comprehensive, and is becoming more popular for various gene expression studies (Nagalakshmi et al., 2008; Wang et al., 2009; Nookaew et al., 2012). RNA-Seq enables genome-wide expression studies on the cellular responses and pathways of microbe affected by drug treatment via differential gene expression profiling (Heo et al., 2014; Qin et al., 2014; Le et al., 2016). This approach has already been used in the cellular responses of C. albicans under several different environmental conditions (Bruno et al., 2010; Cottier et al., 2015). In the present work, we investigated the differentially expressed genes and the pathways involved using high-throughput RNA-Seq technique to explore the mechanisms of MAF-1A on C. albicans.

Materials and Methods

Strain and Growth Conditions

The C. albicans ATCC 10231 was used throughout this study. Strain was preserved in nutrient broth supplemented with 30% glycerol stocked and stored at -80°C and streaked on Sabouraud Dextrose agar (SDA) plates (Sangon, Shanghai, China) at 37°C when used.

Peptide Synthesis

The synthetic MAF-1A peptide is a linear peptide consisting of a 26 amino acid sequences as follows: KKFKETADKLIESAKQ QLESLAKEMK. Peptides were synthesized by Sangon Biotech Co., Ltd. (Shanghai, China). The purity of peptides was confirmed as higher than 95% using analytical reverse-phase high-performance liquid chromatography (RP-HPLC). Peptides were dissolved in sterilized de-ion water to 10 mg/mL and stored -20°C.

MIC Determinations

Antifungal activity of MAF-1A was monitored according to Clinical and Laboratory Standards Institute (CLSI) M27-A2. Briefly, the colonies from 24 hour cultures of C. albicans were picked and resuspended in 0.9% sterile saline and adjusted to 0.5 Mc Farland standard (1–5 × 106 CFU/mL). The yeast stock suspension was then diluted to obtain a starting inoculum of 0.5 × 103 to 2.5 × 103 CFU/mL. Peptides were then serially diluted in RPMI 1640 medium (Sangon, Shanghai, China) in volume of 100 μL per well, giving final concentrations ranging from 5 mg/mL to 0.1 mg/mL in sterile round bottom 96-well polypropylene microplates. Hundred microliter of standardized yeast suspension was then added to each well. After 24 h of incubation at 37°C, the minimum inhibitory concentration (MIC) was defined as the lowest drug concentration that caused 90% growth inhibition compared to drug-free growth control well by visual evaluation. Amphotericin B (Sigma, United States) and fluconazole (Sigma, United States) were used as controls. The MICs were determined in triplicate.

Total RNA Extraction

The cells of C. albicans were inoculated into Sabouraud dextrose broth (SDB) medium (Sangon, Shanghai, China) and cultured at 37°C for 24 h. Before C. albicans were harvested for RNA extraction, the cells were treated with MAF-1A at MIC for 2 h (CA_DT). The untreated cultures were used as the control (CA_D). Total RNA was isolated with RNAiso Plus (Takara, Dalian, China) following the manufacturer’s instructions. Each RNA sample had an A260: A280 ratio between 1.8 and 2.0. RNA purity was checked using the NanoPhotometer® spectrophotometer (Implen, CA, United States). RNA concentration was measured using Qubit® RNA Assay Kit in Qubit® 2.0 Flurometer (Life Technologies, CA, United States). RNA integrity was assessed using the RNA Nano 6000 Assay Kit of the Bioanalyzer 2100 system (Agilent Technologies, CA, United States).

cDNA Library Construction and Illumina RNA-Seq

Libraries construction and RNA-Seq were performed by the Novogene Corporation (Beijing, China). A total amount of 3 μg RNA per sample was used as input material for the RNA sample preparations. Sequencing libraries were generated using NEBNext® UltraTM RNA Library Prep Kit for Illumina® (NEB, United States) following manufacturer’s recommendations and index codes were added to attribute sequences to each sample. Briefly, mRNA was purified from total RNA using poly-T oligo-attached magnetic beads. Fragmentation was carried out using divalent cations under elevated temperature in NEB Next First Strand Synthesis Reaction Buffer. First strand cDNA was synthesized using random hexamer primer and M-MuLV Reverse Transcriptase (RNase H-). Second strand cDNA synthesis was subsequently performed using DNA Polymerase I and RNase H. Remaining over hangs were converted into blunt ends via exonuclease/polymerase activities. After adenylation of 3′ ends of DNA fragments, NEBNext Adaptor with hairpin loop structure were ligated to prepare for hybridization. In order to select cDNA fragments of preferentially 150∼200 bp in length, the library fragments were purified with AMPure XP system (Beckman Coulter, Beverly, United States). Sequencing library quality was assessed on the Agilent Bioanalyzer 2100 system. Paired-end sequencing of cDNA was carried out with Illumina HiseqTM 2000. Raw data was filtered by removing reads with adaptor sequences, as well as low quality reads. Then, clean reads were aligned to the reference genome using TopHat v2.0.12. (Trapnell et al., 2009).

Reads Mapping to the Reference Genome

Reference genome and gene model annotation files of C. albicans SC5314 were downloaded from GenBank (NW_139421). Index of the reference genome was built using Bowtie v2.2.3 and paired-end clean reads were aligned to the reference genome using TopHat v2.0.12. (Trapnell et al., 2009).

Analysis of Differential Expressed Genes

The expression level for each gene is determined by the numbers of reads uniquely mapped to the specific gene and the total number of uniquely mapped reads in the sample. HTSeq v0.6.1 was used to count the reads numbers mapped to each gene. And then expected number of Fragments Per Kilobase of transcript sequence per Millions base pairs sequenced (FPKM) of each gene was calculated based on the length of the gene and reads count mapped to this gene (Trapnell et al., 2010).

Differential expression analysis of two conditions was performed using the DEGSeq R package (1.20.0). The P-values were adjusted using the Benjamini and Hochberg method. Corrected P-value < 0.005 and log2(Fold change) > 1 were set as the threshold for significantly differential expression (Wang et al., 2010).

Enrichment Analysis of Gene Ontology (GO) and KEGG Pathways

Gene Ontology (GO) enrichment analysis of differentially expressed genes (DEGs) was implemented by the GO seq (Young et al., 2010). GO terms with corrected P-value < 0.05 were considered significantly enriched by differential expressed genes. KOBAS 2.0 software was used to test the statistical enrichment of differential expression genes in KEGG pathway (Mao et al., 2005). False discovery rate (FDR) of pathways was calculated. The threshold of significance of pathways was set as FDR < 0.05.

Validation of RNA-Seq by quantitative RT-PCR (qRT-PCR)

To validate the results of RNA-Seq, eight DEGs (five down-regulated and three up-regulated) were selected for qRT-PCR. According to the SYBR Premix Ex TaqTM Kit (Takara, Dalian, China) protocol, the reactions were run on an ABI7300 real-time PCR system using a 20 μL reaction system with reaction procedures of 40 cycles of 95°C for 5 s and 60°C for 30 s and 72°C for 30 s. Gene expression levels were calculated using the 2-ΔΔCt method (Livak and Schmittgen, 2001) and normalized to the abundance of a house-keeping gene 18S rRNA. All samples were examined in triplicate. Target genes using primers listed in Supplementary Table S1.

Results

MIC Assay

The MIC value of the MAF-1A against C. albicans was 0.6 mg/mL.

RNA Sequencing and Gene Prediction

Approximately 50,000,000 raw reads were obtained from each sample. After filtering by quality, 80.30 and 80.01% clean reads from the two groups were mapped to C. albicans genome. The profile of transcriptome sequence data was shown in Table 1. Sequence reads have been deposited in the NCBI Sequence Read Archive (SRA) under accession number PRJNA3751091.

Table 1.

Profile of the transcriptome sequence data.

Sample group CA_D CA_DT
Raw reads 43101176 51894560
Clean reads 42085090 50808194
GC content (%) 37.60 37.09
Total mapped reads 33794586 (80.30%) 40651013 (80.01%)
Uniquely mapped reads 33095119 (78.64%) 40001046 (78.73%)
Multiple mapped reads 699467 (1.66%) 649967 (1.28%)
Open in a new tab

Transcriptional Stress Response of C. albicans to MAF-1A

The RNA sequencing results revealed the differences in distribution and density distribution of gene expression between CA_DT and CA_D (Figure 1). CA_DT was detected 5612 genes expression, CA_D was detected 5546 genes expression. There are 5504 genes co-expression in these two samples, 108 genes were specificity expressed in CA_DT and 42 genes were specificity expressed in CA_D (Figure 2). The volcano plots of the differentially expressed genes demonstrated that 1032 genes in C. albicans were differentially expressed after MAF-1A treatment, with either an increase or decrease of more than twofold (the spots marked in red or green), including 575 up-regulated genes and 457 down-regulated genes (Figure 3).

FIGURE 1.

FIGURE 1

Open in a new tab

The comparison diagram of gene expression level. (A) FPKM (Fragments Per Kilobase of transcript sequence per Millions base pairs sequenced) distribution, (B) FPKM density distribution.

FIGURE 2.

FIGURE 2

Open in a new tab

Gene expression Venn diagram. The number in each circle represents the total number of genes that are expressed in each sample, and the overlapping part of circles indicates that the gene is co-expressed in both samples.

FIGURE 3.

FIGURE 3

Open in a new tab

The volcano plots of the differentially expressed genes. Significantly differentially expressed genes were treated with red dots (up-regulated) or green dots (down-regulated), others indicated with blue dots. The abscissa represents fold change, and the ordinate represents statistical significance.

Verification of Differentially Expressed Genes

To validate the RNA-Seq results, a total of eight genes were selected including five up-regulated and three down-regulated from DGE libraries for qRT-PCR analysis. The results indicated the expression levels have a consistent change for both RNA-Seq and qRT-PCR. Hence, the qRT-PCR results confirmed the reliability of our RNA-Seq data (Figure 4).

FIGURE 4.

FIGURE 4

Open in a new tab

Comparison of eight gene expression levels between RNA-Seq and qRT-PCR.

Analysis of Differential Gene Expression

The Cell Wall Synthesis Related Genes

In this study, two genes involved in the biosynthesis of β-glucan (KRE1, KRE6) were up-regulated 4.32-fold, 1.31-fold, respectively (Table 2); one gene involved in the biosynthesis of mannoprotein (MP65) was up-regulated 5.73-fold (Table 2).

Table 2.

The genes up-regulated or down-regulated response to MAF-1A.

Gene name Description log2Fold_change Corrected P-value
Cell wall synthesis
KRE1 β-1,6-glucan biosynthesis 4.32 1.76 × 10-42
KRE6 β-glucan synthesis-associated protein 1.31 9.06 × 10-13
MP65 Cell surface mannoprotein 5.73 2.77 × 10-5
Cell membrane synthesis
ERG11 Lanosterol 14-alpha demethylase -2.29 8.93 × 10-30
ERG1 Squalene monooxygenase -1.30 7.30 × 10-8
ERG5 Cytochrome P450 61 -1.90 1.24 × 10-39
MVD1 Diphosphomevalonate decarboxylase -1.01 3.05 × 10-5
MET6 5-methyltetrahydropteroyltriglutamate-homocysteine methyltransferase -1.46 1.63 × 10-91
FAS1 Fatty acid synthase subunit beta -1.66 1.31 × 10-88
FAS2 Fatty acid synthase subunit alpha -2.46 2.39 × 10-242
Anti oxidative stress
CAT1 Peroxisomal catalase 2.63 0.00 × 100
SOD1 Superoxide dismutase [Cu-Zn] 1.34 1.07 × 10-24
SOD4 Cell surface superoxide dismutase [Cu-Zn] 4 1.05 3.86 × 10-6
SOD5 Cell surface Cu-only superoxide dismutase 5 1.91 5.54 × 10-6
YHB1 Flavohemoprotein 3.21 3.30 × 10-16
AOX2 Alternative oxidase 2, mitochondrial 1.77 1.22 × 10-32
Open in a new tab

Corrected P-value < 0.005 were set as the threshold for significantly differential expression.

The Cell Membrane Synthesis and Stability Related Genes

Several genes involved in ergosterol biosynthesis pathway were down-regulated about twofold (ERG11, ERG1, ERG5, MET6, MVD1). Among these genes, ERG11expression decreased mostly (Table 2).

FAS1 and FAS2 are fatty acid synthesis genes, which are involved in the membrane biosynthesis. After MAF-1A treatment, FAS1 and FAS2 were down-regulated 1.66-fold and 2.46-fold, respectively (Table 2).

Anti Oxidative Stress Genes

In this work, six genes (CAT1, SOD1, SOD4, SOD5, YHB1, AOX2) were identified to be up-regulated (1.03-fold to 3.21-fold) in C. albicans cells after MAF-1A treatment (Table 2).

Enrichment Analysis of GO and KEGG Pathways

Gene Ontology and KEGG analysis were used to classify the DEGs in the response of C. albicans to MAF-1A. The GO categories significantly enriched (corrected P-value < 0.05) among those DEGs are shown in Tables 3, 4. In the DEGs, a total of 483 up-regulated and 386 down-regulated genes were classified into the following three functional categories: cellular component, molecular function and biological process, respectively. It is noteworthy that within the biological process category of up-regulated DEGs, ribosome, mitochondrion, mitochondrial part, mitochondrial inner membrane, mitochondrial envelope, mitochondrial membrane, mitochondrial membrane part were significantly enriched. The structural constituent of ribosome, oxidoreductase activity terms were enriched in the molecular function category. Oxidation-reduction process, translation terms were enriched in the cellular component category.

Table 3.

The significant enrich Gene Ontology (GO) terms of up-regulated differentially expressed genes (DEGs).

Term_type GO_accession GO_term Corrected P-value
Cellular component GO:0005840 Ribosome 1.16 × 10-6
GO:0044444 Cytoplasmic part 1.20 × 10-4
GO:0030529 Ribonucleoprotein complex 1.03 × 10-3
GO:0005739 Mitochondrion 3.70 × 10-3
GO:0044429 Mitochondrial part 4.00 × 10-3
GO:0005743 Mitochondrial inner membrane 8.03 × 10-3
GO:0005740 Mitochondrial envelope 1.12 × 10-2
GO:0031966 Mitochondrial membrane 2.30 × 10-2
GO:0019866 Organelle inner membrane 2.30 × 10-2
GO:0044455 Mitochondrial membrane part 2.78 × 10-2
GO:0005737 Cytoplasm 3.11 × 10-2
Molecular function GO:0003735 Structural constituent of ribosome 1.16 × 10-6
GO:0016491 Oxidoreductase activity 6.11 × 10-6
GO:0005198 Structural molecule activity 1.02 × 10-3
GO:0005215 Transporter activity 5.19 × 10-3
GO:0022857 Transmembrane transporter activity 9.31 × 10-3
Biological process GO:0055114 Oxidation–reduction process 1.83 × 10-4
GO:0006412 Translation 4.36 × 10-3
GO:0055085 Transmembrane transport 4.14 × 10-2
Open in a new tab

Corrected P-value < 0.05 were set as the threshold for significantly enriched.

Table 4.

The significant enrich GO terms of down-regulated DEGs.

Term_type GO_accession GO_term Corrected P-value
Cellular component GO:0005839 Proteasome core complex 1.27 × 10-2
GO:0000502 Proteasome complex 2.34 × 10-2
Molecular function GO:0003824 Catalytic activity 5.27 × 10-4
GO:0004298 Threonine-type endopeptidase activity 3.02 × 10-3
GO:0070003 Threonine-type peptidase activity 3.02 × 10-3
Biological process GO:1901564 Organonitrogen compound metabolic process 7.91 × 10-3
GO:0008152 Metabolic process 8.95 × 10-3
GO:0044281 Small molecule metabolic process 1.76 × 10-2
GO:0044710 Single-organism metabolic process 1.76 × 10-2
Open in a new tab

Corrected P-value < 0.05 were set as the threshold for significantly enriched.

By enrichment analysis, up-regulated genes were involved in 11 KEGG metabolic pathways, and down-regulated genes were involved in 1 KEGG metabolic pathway (Table 5). In the mapped pathways of the up-regulated genes, the abundant genes mapped onto ribosome, oxidative phosphorylation, peroxisome, carbon metabolism and citrate cycle (TCA cycle). While, the down-regulated genes were primarily related to proteasome.

Table 5.

Differentially expressed genes were involved in significant KEGG metabolic pathways.

Regulated Term ID Input number Background number Corrected P-value
Up Ribosome cal03010 31 140 3.34 × 10-5
Oxidative phosphorylation cal00190 26 129 6.17 × 10-4
Peroxisome cal04146 18 71 6.52 × 10-4
Fatty acid degradation cal00071 11 32 2.02 × 10-3
Valine, leucine, and isoleucine degradation cal00280 9 27 7.74 × 10-3
Glyoxylate and dicarboxylate metabolism cal00630 10 34 7.74 × 10-3
Citrate cycle (TCA cycle) cal00020 12 52 1.24 × 10-2
Carbon metabolism cal01200 26 180 1.63 × 10-2
Alanine, aspartate, and glutamate metabolism cal00250 10 47 4.02 × 10-2
Fatty acid metabolism cal01212 10 50 4.80 × 10-2
Propanoate metabolism cal00640 6 20 4.80 × 10-2
Down Proteasome cal03050 20 63 2.89 × 10-4
Open in a new tab

Corrected P-value < 0.05 were set as the threshold for significantly enriched.

Discussion

Antimicrobial peptides are important components of natural defenses against pathogens. The mechanism of antimicrobial activity for these peptides is generally more complex. AMPs were originally proposed to act via plasma membrane permeabilization, leading to membrane rupture and rapid lysis of microbial cells. Recently, it has been proposed that AMP driven microbial death in addition to membrane disruption (Nguyen et al., 2011; Pasupuleti et al., 2012). In our preliminary work, MAF-1A was shown its remarkable activity anti-C. albicans. To further investigate the mechanism of actions of MAF-1A, we used RNA-Seq to study the transcriptomic profile of C. albicans treated with MAF-1A. The RNA-Seq results showed that the gene expression of C. albicans was extensively altered by MAF-1A treatment. These genes that related to cell wall, plasma membrane and anti-oxidative stress had differentially expressed comparing to control.

The fungal cell wall is essential for sustaining cell morphology and for protection against life threatening environmental conditions (Bowman and Free, 2006; Ruiz-Herrera et al., 2006). The cell wall of C. albicans contains three major macromolecules, including mannoproteins, β-glucan and Chitin (Klis et al., 2001). Composition of the cell wall can be quite dynamic, as it changes during cell response to environmental stresses. C. albicans constantly remodels the cell wall by breaking and reforming chemical bonds within and between polysaccharides to maintain integrity of the cell wall structure (Nather and Munro, 2008). C. albicans could change its expression of cell wall related genes to reduce the toxic effect of caspofungin (Liu et al., 2005; Nailis et al., 2010). In this work, three genes involved in the biosynthesis of cell wall were obviously up-regulated (KRE1, KRE6, MP65) after exposure to MAF-1A. The KRE1, KRE6 encoding proteins are involved in β-glucan biosynthesis, and MP65 encodes cell surface mannoprotein, which plays a significant role in maintaining cell wall integrity, morphogenesis and pathogenicity (Sandini et al., 2011). Therefore, the results indicated that these genes may play a role in the mitigation of cell wall damage.

The fungal plasma membrane is similar to those of other eukaryotic cells, composed of a lipid bilayer with proteins embedded within it. Sterols are major components of fungal plasma membranes. The sterol present in animal plasma membranes is cholesterol, while fungi plasma membranes contain ergosterol (Thevissen et al., 2003). This difference in sterol content is exploited in the mechanisms of antifungal agents (Spampinato and Leonardi, 2013). Itraconazole, widely used antifungal drugs, belongs to the azoles and interferes with ergosterol biosynthesis. Up-regulation of ERG genes were detected in C. albicans cells after exposure to Itraconazole in vitro (De Backer et al., 2001). On the contrary, in vitro exposure of C. albicans to amphotericin B (AMB) is correlated with under-expression of ERG genes (Liu et al., 2005). Binding to ergosterol is sufficient for antifungal activity of AMB and therefore considered the primary mode of fungicidal action (Gray et al., 2012). Besides, AMPs could kill the target cells by disrupting the integrity of fungal membranes (Bahar and Ren, 2013). In the current study, several genes (ERG11, ERG1, ERG5, MET6, MVD1) involved in ergosterol biosynthesis pathway were under-expression. The results indicated that MAF-1A could interfere with ergosterol biosynthesis. We speculate that down-regulation of certain ergosterol biosynthesis genes may reduce the binding of MAF-1A to ergosterol. In addition, FAS1 and FAS2 involved in fatty acid biosynthesis were down-regulated, indicating the composition in cell membrane was also affected by the presence of MAF-1A.

ROS, such as hydrogen peroxide and hydroxyl radicals, cause damage to proteins, lipids and nucleic acids, resulting in irreversible damage and loss of viability. A well-characterized response of eukaryotic microbes to ROS is the rapid induction of mRNAs that encode oxidative stress detoxification and repair proteins. These include catalase (CAT1), glutathione peroxidase (GPX) and superoxide dismutase (SOD) antioxidant-encoding genes (Dantas Ada et al., 2015). Various antifungal agents have been confirmed to cause oxidative damage to C. albicans (Delattin et al., 2014). For example, a number of genes involved in oxidative stress response (YHB1, CTA1, AOX1, and SOD2) were found to be up-regulated upon AMB treatment (Liu et al., 2005). In this research, such oxidative stress-responsive genes in C. albicans are also up-regulated following exposure to MAF-1A. These genes included CAT1, SOD1, SOD4, SOD5, AOX2, and YHB1, encodes catalase, superoxide dismutase, alternative oxidases and flavohemoprotein, respectively.

The significantly enriched GO term in the cellular component category suggest that nearly all cellular components were affected including the ribosomes, mitochondrion, cytoplasm, and organelle inner membrane. The significant enrichment of GO terms associated with molecular function indicates that the transcription levels of structural constituent of ribosome, oxidoreductase, structural molecule activity, transmembrane transporter genes were significantly changed. In addition, KEGG analysis showed that twelve metabolic pathways were affected in C. albicans upon MAF-1A treatment. Three metabolic pathways, including “ribosome”, “oxidative phosphorylation”, and “citrate cycle”, are the metabolic pathways of protein biosynthesis, cellular respiration and ATP generation.

It is widely accepted that membrane interaction is a key factor for antimicrobial activity of AMPs. Furthermore, AMPs can also act up on multiple cell targets, involving a mixed multi-hit mechanism (Guilhelmelli et al., 2013; van der Weerden et al., 2013; Silva et al., 2014; Shah et al., 2016). Considering the changes of expression pattern, it is strongly suggested that C. albicans inhibition caused by MAF-1A should be a result of multiple and complementary actions, involving in cell wall, plasma membrane, as well as protein synthesis and energy metabolism (Figure 5). It should be noted that this study has examined only on transcriptional level and further experiments are required to determine the anti-C. albicans key mechanisms.

FIGURE 5.

FIGURE 5

Open in a new tab

Schematic overview of the proposed mechanisms of action of MAF-1A.

Conclusion

We analyzed the gene expression changes for C. albicans under treatment of MAF-1A using RNA-seq. The results from this study suggest that MAF-1A induces complex responses in C. albicans and MAF-1A has the potential to inhibit C. albicans growth through affect multi-targets of C. albicans cells. This study provides important insights into the mechanisms of action of MAF-1A and the responds of C. albicans under AMPs stress. However, further studies are needed to determine the key mechanisms that C. albicans responses to MAF-1A.

Author Contributions

TW and JW designed the project, analyzed data and wrote the manuscript. TW, JX, YZ, and XM carried out the experiments. YW, GG, and XS reviewed the manuscript.

Conflict of Interest Statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Acknowledgments

This work was supported by grants from the National Natural Science Foundation of China (81360254), the Guiyang Science and Technology Bureau and Guizhou Medical University United Foundation (GY2015-23), the Science and Technology Program of Guizhou Province Agricultural research Project [NY (2014)3054].

Footnotes

Supplementary Material

The Supplementary Material for this article can be found online at: http://journal.frontiersin.org/article/10.3389/fmicb.2017.00894/full#supplementary-material

Click here for additional data file. (56.5KB, DOC)

References

  1. Bahar A. A., Ren D. (2013). Antimicrobial peptides. Pharmaceuticals 6 1543–1575. 10.3390/ph6121543 [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bowman S. M., Free S. J. (2006). The structure and synthesis of the fungal cell wall. Bioessays 28 799–808. 10.1002/bies.20441 [DOI] [PubMed] [Google Scholar]
  3. Bruno V. M., Wang Z., Marjani S. L., Euskirchen G. M., Martin J., Sherlock G., et al. (2010). Comprehensive annotation of the transcriptome of the human fungal pathogen Candida albicans using RNA-seq. Genome Res. 20 1451–1458. 10.1101/gr.109553.110 [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cottier F., Tan A. S., Chen J., Lum J., Zolezzi F., Poidinger M., et al. (2015). The transcriptional stress response of Candida albicans to weak organic acids. G3 5 497–505. 10.1534/g3.114.015941 [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cruz J., Ortiz C., Guzmán F., Fernández-Lafuente R., Torres R. (2014). Antimicrobial peptides: promising compounds against pathogenic microorganisms. Curr. Med. Chem. 21 2299–2321. 10.2174/0929867321666140217110155 [DOI] [PubMed] [Google Scholar]
  6. Dantas Ada S., Day A., Ikeh M., Kos I., Achan B., Quinn J. (2015). Oxidative stress responses in the human fungal pathogen, Candida albicans. Biomolecules 5 142–165. 10.3390/biom5010142 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. De Backer M. D., Ilyina T., Ma X. J., Vandoninck S., Luyten W. H., Vanden Bossche H. (2001). Genomic profiling of the response of Candida albicans to itraconazole treatment using a DNA microarray. Antimicrob. Agents Chemother. 45 1660–1670. 10.1128/AAC.45.6.1660-1670.2001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Delattin N., Cammue B. P., Thevissen K. (2014). Reactive oxygen species-inducing antifungal agents and their activity against fungal biofilms. Future Med. Chem. 6 77–90. 10.4155/fmc.13.189 [DOI] [PubMed] [Google Scholar]
  9. Eggimann P., Garbino J., Pittet D. (2003). Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect. Dis. 3 685–702. 10.1016/S1473-3099(03)00801-6 [DOI] [PubMed] [Google Scholar]
  10. Fu P., Wu J., Guo G. (2009). Purification and molecular identificationn of an antifungal peptide from the hemolymph of Musca domestica (housefly). Cell Mol. Immunol. 6 245–251. 10.1038/cmi.2009.33 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gray K. C., Palacios D. S., Dailey I., Endo M. M., Uno B. E., Wilcock B. C., et al. (2012). Amphotericin primarily kills yeast by simply binding ergosterol. Proc. Natl. Acad. Sci. U.S.A. 109 2234–2239. 10.1073/pnas.1117280109 [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Guilhelmelli F., Vilela N., Albuquerque P., Derengowski Lda S., Silva-Pereira I., Kyaw C. M. (2013). Antibiotic development challenges: the various mechanisms of action of antimicrobial peptides and of bacterial resistance. Front. Microbiol. 4:353 10.3389/fmicb.2013.00353 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Guilhelmelli F., Vilela N., Smidt K. S., de Oliveira M. A., da Cunha Morales Álvares A., Rigonatto M. C., et al. (2016). Activity of scorpion venom-derived antifungal peptides against planktonic cells of Candida spp. and Cryptococcus neoformans and Candida albicans biofilms. Front. Microbiol. 7:1844 10.3389/fmicb.2016.01844 [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Heo A., Jang H. J., Sung J. S., Park W. (2014). Global transcriptome and physiological responses of Acinetobacter oleivorans DR1 exposed to distinct classes of antibiotics. PLoS ONE 9:e110215 10.1371/journal.pone.0110215 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Horn D. L., Neofytos D., Anaissie E. J., Fishman J. A., Steinbach W. J., Olyaei A. J., et al. (2009). Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin. Infect. Dis. 48 1695–1703. 10.1086/599039 [DOI] [PubMed] [Google Scholar]
  16. Khan A., Ahmad A., Ahmad Khan L., Padoa C. J., van Vuuren S., Manzoor N. (2015). Effect of two monoterpene phenols on antioxidant defense system in Candida albicans. Microb. Pathog. 80 50–56. 10.1016/j.micpath.2015.02.004 [DOI] [PubMed] [Google Scholar]
  17. Klis F. M., de Groot P., Hellingwerf K. (2001). Molecular organization of the cell wall of Candida albicans. Med. Mycol. 39(Suppl. 1), 1–8. 10.1080/mmy.39.1.1.8-0 [DOI] [PubMed] [Google Scholar]
  18. Lakshmaiah Narayana J., Chen J. Y. (2015). Antimicrobial peptides: possible anti-infective agents. Peptides 72 88–94. 10.1016/j.peptides.2015.05.012 [DOI] [PubMed] [Google Scholar]
  19. Le C. F., Gudimella R., Razali R., Manikam R., Sekaran S. D. (2016). Transcriptome analysis of Streptococcus pneumoniae treated with the designed antimicrobial peptides, DM3. Sci. Rep. 6:26828 10.1038/srep26828 [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Linares C. E., Giacomelli S. R., Altenhofen D., Alves S. H., Morsch V. M., Schetinger M. R. (2013). Fluconazole and amphotericin-B resistance are associated with increased catalase and superoxide dismutase activity in Candida albicans and Candida dubliniensis. Rev. Soc. Bras. Med. Trop. 46 752–758. 10.1590/0037-8682-0190-2013 [DOI] [PubMed] [Google Scholar]
  21. Liu T. T., Lee R. E., Barker K. S., Lee R. E., Wei L., Homayouni R., et al. (2005). Genome-wide expression profiling of the response to azole, polyene, echinocandin, and pyrimidine antifungal agents in Candida albicans. Antimicrob. Agents Chemother. 49 2226–2236. 10.1128/AAC.49.6.2226-2236.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Livak K. J., Schmittgen T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 402–408. 10.1006/meth.2001.1262 [DOI] [PubMed] [Google Scholar]
  23. Lo H. J., Tseng K. Y., Kao Y. Y., Tsao M. Y., Lo H. L., Yang Y. L. (2015). Cph1p negatively regulates MDR1 involved in drug resistance in Candida albicans. Int. J. Antimicrob. Agents 45 617–621. 10.1016/j.ijantimicag.2015.01.017 [DOI] [PubMed] [Google Scholar]
  24. Lu Y., Su C., Liu H. (2014). Candida albicans hyphal initiation and elongation. Trends Microbiol. 22 707–714. 10.1016/j.tim.2014.09.001 [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Luo Z. H., Wu J. W., Fu P., Guo G., Jiang S. (2013). Effect of the synthetic Musca domestica antifungal peptide-1a (MAF-1A) on the pathogenicity of Candida albicans. J. Third Military Med. Univ. 35 2203–2207. [Google Scholar]
  26. Mahlapuu M., Håkansson J., Ringstad L., Björn C. (2016). Antimicrobial peptides: an emerging category of therapeutic agents. Front. Cell Infect. Microbiol. 6:194 10.3389/fcimb.2016.00194 [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Malmsten M. (2014). Antimicrobial peptides. UPS J. Med. Sci. 119 199–204. 10.3109/03009734.2014.899278 [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Mao X., Cai T., Olyarchuk J. G., Wei L. (2005). Automated genome annotation and pathway identification using the KEGG Orthology (KO) as a controlled vocabulary. Bioinformatics 21 3787–3793. 10.1093/bioinformatics/bti430 [DOI] [PubMed] [Google Scholar]
  29. Nagalakshmi U., Wang Z., Waern K., Shou C., Raha D., Gerstein M., et al. (2008). The transcriptional landscape of the yeast genome defined by RNA sequencing. Science 320 1344–1349. 10.1126/science.1158441 [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Nailis H., Vandenbosch D., Deforce D., Nelis H. J., Coenye T. (2010). Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms. Res. Microbiol. 161 284–292. 10.1016/j.resmic.2010.02.004 [DOI] [PubMed] [Google Scholar]
  31. Nather K., Munro C. A. (2008). Generating cell surface diversity in Candida albicans and other fungal pathogens. FEMS Microbiol. Lett. 285 137–145. 10.1111/j.1574-6968.2008.01263.x [DOI] [PubMed] [Google Scholar]
  32. Nguyen L. T., Haney E. F., Vogel H. J. (2011). The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol. 29 464–472. 10.1016/j.tibtech.2011.05.001 [DOI] [PubMed] [Google Scholar]
  33. Nookaew I., Papini M., Pornputtapong N., Scalcinati G., Fagerberg L., Uhlén M., et al. (2012). A comprehensive comparison of RNA-Seq-based transcriptome analysis from reads to differential gene expression and cross-comparison with microarrays: a case study in Saccharomyces cerevisiae. Nucleic Acids Res. 40 10084–10097. 10.1093/nar/gks804 [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Omardien S., Brul S., Zaat S. A. (2016). Antimicrobial activity of cationic antimicrobial peptides against gram-positives: current progress made in understanding the mode of action and the response of bacteria. Front. Cell Dev. Biol. 4:111 10.3389/fcell.2016.00111 [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Pasupuleti M., Schmidtchen A., Malmsten M. (2012). Antimicrobial peptides: key components of the innate immune system. Crit. Rev. Biotechnol. 32 143–171. 10.3109/07388551.2011.594423 [DOI] [PubMed] [Google Scholar]
  36. Pushpanathan M., Gunasekaran P., Rajendhran J. (2013). Antimicrobial peptides: versatile biological properties. Int. J. Pept. 2013:675391 10.1155/2013/675391 [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Qin N., Tan X., Jiao Y., Liu L., Zhao W., Yang S., et al. (2014). RNA-Seq-based transcriptome analysis of methicillin-resistant Staphylococcus aureus bioflm inhibition by ursolic acid and resveratrol. Sci. Rep. 4:5467 10.1038/srep05467 [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Ruiz-Herrera J., Elorza M. V., Valentín E., Sentandreu R. (2006). Molecular organization of the cell wall of Candida albicans and its relation to pathogenicity. FEMS Yeast Res. 6 14–29. 10.1111/j.1567-1364.2005.00017.x [DOI] [PubMed] [Google Scholar]
  39. Sandini S., Stringaro A., Arancia S., Colone M., Mondello F., Murtas S., et al. (2011). The MP65 gene is required for cell wall integrity, adherence to epithelial cells and biofilm formation in Candida albicans. BMC Microbiol. 11:106 10.1186/1471-2180-11-106 [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Scocchi M., Mardirossian M., Runti G., Benincasa M. (2016). Non-membrane permeabilizing modes of action of antimicrobial peptides on bacteria. Curr. Top. Med. Chem. 16 76–88. 10.2174/1568026615666150703121009 [DOI] [PubMed] [Google Scholar]
  41. Seo M. D., Won H. S., Kim J. H., Mishig-Ochir T., Lee B. J. (2012). Antimicrobial peptides for therapeutic applications: a review. Molecules 17 12276–12286. 10.3390/molecules171012276 [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Shah P., Hsiao F. S., Ho Y. H., Chen C. S. (2016). The proteome targets of intracellular targeting antimicrobial peptides. Proteomics 16 1225–1237. 10.1002/pmic.201500380 [DOI] [PubMed] [Google Scholar]
  43. Silva P. M., Gonçalves S., Santos N. C. (2014). Defensins: antifungal lessons from eukaryotes. Front. Microbiol. 5:97 10.3389/fmicb.2014.00097 [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Spampinato C., Leonardi D. (2013). Candida infections, causes, targets, and resistance mechanisms: traditional and alternative antifungal agents. Biomed. Res. Int. 2013:204237 10.1155/2013/204237 [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Tavares L. S., Silva C. S., de Souza V. C., da Silva V. L., Diniz C. G., Santos M. O. (2013). Strategies and molecular tools to fight antimicrobial resistance: resistome, transcriptome, and antimicrobial peptides. Front. Microbiol. 4:412 10.3389/fmicb.2013.00412 [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Thevissen K., Ferket K. K., François I. E., Cammue B. P. (2003). Interactions of antifungal plant defensins with fungal membrane components. Peptides 24 1705–1712. 10.1016/j.peptides.2003.09.014 [DOI] [PubMed] [Google Scholar]
  47. Trapnell C., Pachter L., Salzberg S. L. (2009). TopHat: discovering splice junctions with RNA-Seq. Bioinformatics 25 1105–1111. 10.1093/bioinformatics/btp120 [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Trapnell C., Williams B. A., Pertea G., Mortazavi A., Kwan G., van Baren M. J., et al. (2010). Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat. Biotechnol. 28 511–515. 10.1038/nbt.1621 [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. van der Weerden N. L., Bleackley M. R., Anderson M. A. (2013). Properties and mechanisms of action of naturally occurring antifungal peptides. Cell Mol. Life Sci. 70 3545–3570. 10.1007/s00018-013-1260-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Wang L., Feng Z., Wang X., Wang X., Zhang X. (2010). DEGseq: an R package for identifying differentially expressed genes from RNA-seq data. Bioinformatics 26 136–138. 10.1093/bioinformatics/btp612 [DOI] [PubMed] [Google Scholar]
  51. Wang Z., Gerstein M., Snyder M. (2009). RNA-Seq: a revolutionary tool for transcriptomics. Nat. Rev. Genet. 10 57–63. 10.1038/nrg2484 [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Young M. D., Wakefield M. J., Smyth G. K., Oshlack A. (2010). Gene ontology analysis for RNA-seq: accounting for selection bias. Genome Biol. 11:R14 10.1186/gb-2010-11-2-r14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Zhou J., Kong L., Fang N., Mao B., Ai H. (2016). Synthesis and functional characterization of MAF-1A peptide derived from the larvae of housefly, Musca domestica (Diptera: Muscidae). J. Med. Entomol. 53 1467–1472. 10.1093/jme/tjw110 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Click here for additional data file. (56.5KB, DOC)

Articles from Frontiers in Microbiology are provided here courtesy of Frontiers Media SA

RESOURCES